Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression

被引:164
作者
Peng, Gang
Greenwell-Wild, Teresa
Nares, Salvador
Jin, Wenwen
Lei, Ke Jian
Rangel, Zoila G.
Munson, Peter J.
Wahl, Sharon M.
机构
[1] NIDCR, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA
[2] NIH, Math & Stat Comp Lab, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA
关键词
D O I
10.1182/blood-2006-10-051763
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
HIV-1 recognition by, interaction with, and/or infection of CD4(+)CCR5(+) tissue macrophages and dendritic cells (DCs) play important roles in HIV-1 transmission and pathogenesis. By comparison, circulating CD4(+)CCR5(+) monocytes appear relatively resistant to HIV-1, and a fundamental unresolved question involves deciphering restriction factors unique to this precursor population. Not only do monocytes, relative to macrophages, possess higher levels of the innate resistance factor APOBEC3G, but we uncovered APOBEC3A, not previously associated with anti-HIV activity, as being critical in monocyte resistance. Inversely correlated with susceptibility, silencing of APOBEC3A renders monocytes vulnerable to HIV-1. Differences in promiscuity of monocytes, macrophages, and DCs can be defined, at least partly, by disparities in APOBEC expression, with implications for enhancing cellular defenses against HIV-1.
引用
收藏
页码:393 / 400
页数:8
相关论文
共 52 条
[1]   Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing [J].
Bennasser, Y ;
Le, SY ;
Benkirane, M ;
Jeang, KT .
IMMUNITY, 2005, 22 (05) :607-619
[2]   Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease [J].
Berger, EA ;
Murphy, PM ;
Farber, JM .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :657-700
[3]   Cytidine deamination of retroviral DNA by diverse APOBEC proteins [J].
Bishop, KN ;
Holmes, RK ;
Sheehy, AM ;
Davidson, NO ;
Cho, SJ ;
Malim, MH .
CURRENT BIOLOGY, 2004, 14 (15) :1392-1396
[4]   APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells [J].
Bogerd, HP ;
Wiegand, HL ;
Doehle, BP ;
Lueders, KK ;
Cullen, BR .
NUCLEIC ACIDS RESEARCH, 2006, 34 (01) :89-95
[5]   APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons [J].
Chen, H ;
Lilley, CE ;
Yu, Q ;
Lee, DV ;
Chou, J ;
Narvaiza, I ;
Landau, NR ;
Weitzman, MD .
CURRENT BIOLOGY, 2006, 16 (05) :480-485
[6]   RETRACTED: Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells (Retracted Article. See vol 466, pg 276, 2010) [J].
Chiu, YL ;
Soros, VB ;
Kreisberg, JF ;
Stopak, K ;
Yonemoto, W ;
Greene, WC .
NATURE, 2005, 435 (7038) :108-114
[7]   Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif [J].
Doehle, BP ;
Schäfer, A ;
Cullen, BR .
VIROLOGY, 2005, 339 (02) :281-288
[8]   Identification of cell surface targets for HIV-1 therapeutics using genetic screens [J].
Dunn, SJ ;
Khan, MH ;
Chan, UA ;
Scearce, RL ;
Melara, CL ;
Paul, AM ;
Sharma, V ;
Bih, FY ;
Holzmayer, TA ;
Luciw, PA ;
Abo, A .
VIROLOGY, 2004, 321 (02) :260-273
[9]   The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes [J].
Ganesh, L ;
Burstein, E ;
Guha-Nijogi, A ;
Louder, MK ;
Mascola, JR ;
Klomp, LWJ ;
Wijmenga, C ;
Duckett, CS ;
Nabel, GJ .
NATURE, 2003, 426 (6968) :853-857
[10]   Dynamics of viral load in plasma and HIV DNA in lymphocytes during highly active antiretroviral therapy (HAART): High viral burden in macrophages after 1 year of treatment [J].
Garbuglia, AR ;
Zaccarelli, M ;
Calcaterra, S ;
Cappiello, G ;
Marini, R ;
Benedetto, A .
JOURNAL OF CHEMOTHERAPY, 2001, 13 (02) :188-194